Pylum Biosciences
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Kimball Way, South San Francisco, Ca...Phone Number
(650) 243-2951Website
www.pylumbio.comRevenue
<$5 MillionIndustry
About Pylum Biosciences
Pylum Biosciences has developed a patented Avidocin platform technology that creates bactericidal protein complexes specifically targeting bacterial pathogens. The company offers solutions for bacterial diseases, microbiome applications, and animal health and food safety. Their innovative Avidocin and Purocin proteins demonstrate narrow-spectrum antibacterial capabilities. Pylum Biosciences aims to partner with organizations to advance their technology and address critical health challenges.Explore more
SIC Code 87,873NAICS Code 54,541Show morePylum Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Pylum Biosciences
Compare insights from companies similar to Pylum Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Pylum Biosciences Tech Stack
A closer look at the technologies used by Pylum Biosciences
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Pylum Biosciences
Sign Up For FreeTo access detailed company insights
Pylum Biosciences has developed a patented Avidocin platform technology that creates bactericidal protein complexes specifically targeting bacterial pathogens. The company offers solutions for bacterial diseases, microbiome applications, and animal health and food safety. Their innovative Avidocin and Purocin proteins demonstrate narrow-spectrum an... Read More
